z-logo
open-access-imgOpen Access
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology
Author(s) -
Potjewyd Frances M.,
AnnorGyamfi Joel K.,
Aubé Jeffrey,
Chu Shaoyou,
Conlon Ivie L.,
Frankowski Kevin J.,
Guduru Shiva K. R.,
Hardy Brian P.,
Hopkins Megan D.,
Kinoshita Chizuru,
Kireev Dmitri B.,
Mason Emily R.,
Moerk Charles T.,
Nwogbo Felix,
Pearce Kenneth H.,
Richardson Timothy I.,
Rogers David A.,
Soni Disha M.,
Stashko Michael,
Wang Xiaodong,
Wells Carrow,
Willson Timothy M.,
Frye Stephen V.,
Young Jessica E.,
Axtman Alison D.
Publication year - 2022
Publication title -
alzheimer's and dementia: translational research and clinical interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.49
H-Index - 30
ISSN - 2352-8737
DOI - 10.1002/trc2.12253
Subject(s) - microglia , mertk , cytotoxicity , biology , computational biology , neuroscience , receptor , chemistry , microbiology and biotechnology , biochemistry , immunology , in vitro , receptor tyrosine kinase , inflammation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here